Achieving control of diabetic risk factors in primary care settings

American Journal of Managed Care

Volumn 7, Issue 4, 2001, Pages 411-421

  Bertoni, A G ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; NICOTINIC ACID; NITRENDIPINE; PIOGLITAZONE; RAMIPRIL; RESIN; ROSIGLITAZONE; SULFONYLUREA; THIAZOLIDINE DERIVATIVE; TRIACYLGLYCEROL; UNINDEXED DRUG;

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIET THERAPY; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; DRUG TOLERABILITY; DYSLIPIDEMIA; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE; MEDICAL ASSESSMENT; METABOLIC DISORDER; MONOTHERAPY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; EDUCATION, MEDICAL, CONTINUING; HUMANS; HYPERLIPIDEMIAS; PATIENT COMPLIANCE; PREVALENCE; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; RISK FACTORS; UNITED STATES;

EID: 0035051581     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Diabetes trends in the US. 1990-1998
2. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994
3. Long-term complications of diabetes mellitus
4. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993
5. Insulin secretion in non-insulin-dependent diabetes mellitus
6. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - A genetically programmed failure of the beta cell to compensate for insulin resistance
7. Pharmacologic therapy for type 2 diabetes mellitus
8. The pathophysiology of diabetic complications: How much does the glucose hypothesis explain?
9. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
10. Insulin resistance and its consequences. NIDDM and coronary heart disease
11. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group
12. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
13. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes
14. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group
15. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial
16. National High Blood Pressure Education Program Working Group report on hypertension in diabetes
17. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus
18. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group
19. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
20. Diabetes, lipids and atherosclerosis
21. Management of dyslipidemia in adults with diabetes
22. Stratifying patients at risk of diabetic complications
23. Is having a regular provider of diabetes care related to intensity of care and glycemic control?
24. Population-based assessment of the level of care among adults with diabetes in the US
25. Ambulatory medical care for diabetes
26. Primary care and the risk of complications and death in a national sample of U.S. elders with diabetes
27. Standards of care for diabetes
28. Clinical practice recommendations 2000
29. The clinical utility of glycosylated hemoglobin
30. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-month outpatient trial
31. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial
32. Appropriate insulin regimes for type 2 diabetes: A multicenter randomized crossover study
33. Rosiglitazone for type 2 diabetes mellitus
34. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: A randomized controlled trial
35. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group
36. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
37. Summary of revisions for the 2001 clinical practice recommendations
38. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
39. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial
40. The cost effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors
41. Angiotensin II receptor antagonists in arterial hypertension
42. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group
43. Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas
44. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
45. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators
46. Aspirin therapy in diabetes
47. Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes
48. Measures of disease control in Medicare beneficiaries with diabetes mellitus
49. Use of services by diabetes patients in managed care organizations: Development of a diabetes surveillance system. (CDC Diabetes in Managed Care Work Group)
50. Risk and protective factors associated with screening for complications of diabetes in a health maintenance organization setting
51. 1c after a physician education project
52. Diabetes care for Medicare beneficiaries. Attitudes and behaviors of primary care physicians
53. Implementing practice guidelines for diabetes care using problem-based learning. A prospective controlled trial using firm systems
54. Preventive care practices for diabetes management in two primary care samples
55. Diabetes in urban African-Americans, XVI: Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes
56. Diabetes in urban African-Americans, XV: Identification of barriers to provider adherence to management protocols
57. Nutrition management of type 2 diabetes by primary care physicians. Reported use and barriers
58. Diabetes self-management: Self-reported recommendations and patterns in a large population
59. Community diabetes care: A 10-year perspective
60. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: A randomized, controlled trial
61. Diabetes management in a health maintenance organization: Efficacy of care management using cluster visits